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ABSTRACT: Membrane permeability to ions and small molecules is believed to be a critical step in the pathology of
Alzheimer’s disease (AD). Interactions of oligomers formed by amyloid-β (Aβ) peptides with the plasma cell membrane are
believed to play a fundamental role in the processes leading to membrane permeability. Among the family of Aβs, pyroglutamate
(pE)-modified Aβ peptides constitute the most abundant oligomeric species in the brains of AD patients. Although membrane
permeability mechanisms have been studied for full-length Aβ1−40/42 peptides, these have not been sufficiently characterized for
the more abundant AβpE3−42 fragment. Here we have compared the adsorbed and membrane-inserted oligomeric species of
AβpE3−42 and Aβ1−42 peptides. We find lower concentrations and larger dimensions for both species of membrane-associated
AβpE3−42 oligomers. The larger dimensions are attributed to the faster self-assembly kinetics of AβpE3−42, and the lower
concentrations are attributed to weaker interactions with zwitterionic lipid headgroups. While adsorbed oligomers produced little
or no significant membrane structural damage, increased membrane permeabilization to ionic species is understood in terms of
enlarged membrane-inserted oligomers. Membrane-inserted AβpE3−42 oligomers were also found to modify the mechanical
properties of the membrane. Taken together, our results suggest that membrane-inserted oligomers are the primary species
responsible for membrane permeability.
Amyloid-β (Aβ) peptides play a fundamental role inAlzheimer’s disease (AD).1,2 They are formed by
enzymatic cleavage of the amyloid precursor protein (APP).3
Although amyloid fibrils were originally believed to be the
cytotoxic species in AD,4 the emphasis has shifted toward
smaller oligomers,5−15 and a growing body of evidence
indicates that intermediate Aβ oligomers are the toxic species
while fibrils appear not to be involved in cytotoxicity.16−21
Among the family of Aβ peptides, oligomers composed of
pyroglutamate (pE)-modified Aβs appear to be intimately
involved in AD,18,22−24 as they constitute the most abundant
oligomeric species in the brains of AD patients, but their
amount is significantly smaller in brains of age-matched
individuals with normal cognition.18,22−24 One of the most
abundant species, the AβpE3−42 fragment, is generated by
cleavage of the first two amino acids at the N-terminus of
Aβ1−42, leaving a glutamate (E) residue in position 3. The
pyroglutamate (pE) residue is subsequently generated by
intramolecular dehydration.18,24
Self-assembly of Aβ peptides into polymorphic structures and
their binding to lipid membranes are key processes in the
pathogenesis of AD.17,25−28 Although the exact molecular
mechanisms of cell dysfunction are insufficiently understood,
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they involve the interaction of oligomeric species with the
plasma cell membrane.17,25,26,29−31 Depending on lipid
composition, membranes can promote the conformational
changes of Aβs that lead to the formation of toxic β-sheet
structures and serve as nucleation sites for faster self-assembly.
In addition, ganglioside-containing membranes have been
found to play a role in altering the aggregation pathways of
Aβ.32 On the other hand, Aβ oligomers can induce
permeabilization of the membrane to unregulated passage of
small molecules and ions.2,17,26,33,34 Potential mechanisms of
membrane permeabilization include carpeting, pore formation,
and the detergent effect.17,33−36 Also, recent solid state nuclear
magnetic resonance (NMR) studies of Aβ and the islet amyloid
polypeptide (IAPP) peptides have shown similarities between
the modes of membrane permeabilization of these amyloid
peptides and those of the better studied antimicrobial peptides
(AMPs).37,38 Permeabilization mechanisms appear not to be
mutually exclusive; for instance, pore formation appears to
occur prior to membrane fragmentation.39 All permeabilization
mechanisms ultimately lead to changes in the cellular ionic
concentration, producing a loss of cell homeostasis and
subsequent cell death. These processes have been characterized
for full-length Aβ1−40/42, but similar studies are missing for the
AβpE3−42 fragment.
AβpE3−42 is more hydrophobic than Aβ1−42 because of the
loss of negative charges from residues Asp1 and Glu3 and the
formation of the lactam ring in the pE residue. This increased
hydrophobicity affects the kinetics of self-assembly, as well as
the interactions of the peptide with the membrane lipids. Here,
we examine different mechanisms of membrane permeability
induced by AβpE3−42 peptides. We compare the kinetics of self-
assembly for AβpE3−42 and Aβ1−42 and examine the relationship
between self-assembly and membrane binding. We used a
mixture of phosphoethanolamine (PE) and phosphoserine
(PS) lipid headgroups because these are dominant lipid
components in the brains of the elderly,40 and these levels
have been found to change in AD brains.41 We find lower
concentrations of AβpE3−42 oligomers adsorbed on membrane
surfaces, likely reflecting the weaker interactions between the
more hydrophobic AβpE3−42 peptides and the lipid heads. The
faster kinetics of AβpE3−42 self-assembly leads to larger
dimensions of the adsorbed AβpE3−42 oligomers. These
adsorbed oligomers produced little or no significant damage
to the membrane. Membrane permeabilization to ionic species
was observed as pore activity and can be understood as a result
of oligomers inserted into the membrane.
■ MATERIALS AND METHODS
Peptide Handling. Both Aβ1−42 and AβpE3−42, >90% purity
as provided by the manufacturer (Bachem, Torrance, CA),
were first dissolved in 1% ammonium hydroxide until the
peptides were completely dissolved. They were subsequently
sonicated for approximately 2 min. The desired amount of
peptide was aliquoted and lyophilized using a lyophilizer
(FreeZone 2.5 Plus, Labconco, Kansas City, KS). The aliquots
were stored at −80 °C for a maximum of 3 months until they
were used. For every experiment, aliquoted peptides were taken
from −80 °C and hydrated in Tris (pH 7.4) or HEPES (pH
7.0) buffer solutions. The peptide concentration was measured
using the 280 nm UV absorbance (extinction coefficient: ε =
1490 M−1 cm−1).
Thioflavin-T (ThT) Assays. A stock solution of 500 μM
ThT in water was prepared, and 2 μL was added to 100 μL of
10 mM HEPES [20 mM MgCl2 and 150 mM NaCl (pH 7.0)]
buffer in 96-well black-walled plates (Nunc) to make 10 μM
ThT solutions. For peptides, 20 mM NaOH was used to
dissolve lyophilized aliquot peptides and prevent aggregation.
After that, the peptide solution was diluted with HEPES to its
final peptide concentration in the plate well, and the NaOH
content was maintained at <10% of the total volume. ThT
fluorescence (450 nm excitation, 490 nm emission) was
monitored every 5 min at 25 °C for the indicated times
using a SPECTRAmax Gemini EM fluorescent plate reader
(Molecular Devices, Sunnyvale, CA). The obtained curves were
fit using the sigmoidal curve in eq 142
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where t is the time, t1/2 is the time to reach half-maximal ThT
fluorescence, F0 is the initial fluorescence intensity, a is the
amplitude of the maximal intensity, and k is the rate constant.
The lag phase time was calculated from the fitting parameters
obtained above using
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Lipid Bilayer Preparation for Atomic Force Micros-
copy (AFM) Experiments. For liposome preparation, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE)
and 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) lipids
were used in a 1:1 ratio (both purchased from Avanti Polar
Lipids, Alabaster, AL). Liposomes were prepared by mixing 20
μL of each lipid (5 mg/mL) dissolved in chloroform and
allowed to dry overnight in vacuum. The dried lipid film was
hydrated with a peptide solution to facilitate incorporation of
the peptide in the lipid bilayer, resulting in proteoliposome
formation. For imaging, peptide:lipid ratios in the range of 1:10
to 1:2 were used, while the peptide:lipid ratios for force
mapping were 1:10. For the preparation of control liposomes,
200 μL of 25 mM Tris buffer [300 mM NaCl (pH 7.4)] were
used. The resulting liposome and proteoliposome suspensions
were vortexed occasionally for approximately 1 h for better
hydration. The large multilamellar vesicles formed with this
procedure were sonicated for 5 min. These suspensions were
subsequently extruded using 100 nm filters to produce small
unilamellar vesicles. Supported lipid bilayers were formed by
(proteo)liposome rupture and fusion on the mica sub-
strate.43−45 Lipid concentrations of 0.1−1 mg/mL were
deposited on freshly cleaved mica and incubated for ∼10 min
on a hot plate above the lipid transition temperature to facilitate
fusion of the ruptured proteoliposomes on the mica surface. As
a last step, samples were rinsed with buffer to remove
unruptured proteoliposomes still in solution. For incubation
of AβpE3−42 on preformed lipid bilayer experiments, liposomes
were allowed to form supported lipid bilayers on mica. The
formation of bilayer patches was verified by AFM before
incubation in peptide solutions. AβpE3−42 was injected in a
buffer solution at the final concentration of 20 μM for a given
time at room temperature.
AFM Imaging. Topographic images were acquired using a
Multimode atomic force microscope equipped with a Nano-
scope V controller (Bruker, Santa Barbara, CA). Silicon
cantilevers with a spring constant of 48 N/m (NSC11, JPK)
were used for imaging in air using tapping mode. Silicon nitride
cantilevers with spring constants of 0.08 N/m (OMCL-TR400,
Olympus) were employed for imaging in fluid using tapping
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mode. Resonance frequencies of ∼8 kHz and drive amplitudes
under 100 mV were used. The Nanoscope software was used
for analyzing imaging data. Particle analysis was used to
measure the number of membrane-associated oligomers.
Section analysis was used for measuring widths and heights
of membrane-associated oligomers. Oligomer widths were
measured as full widths at half the maximal height (fwhm) in
section profiles, and these values were corrected to take tip
widening effects into account. On the basis of previous
models,43,46,47 tip widening of the inserted oligomers was
modeled as a spherical tip of radius R in contact with a spherical
cap of radius r protruding a height h above the surface of the
lipid bilayer (eqs 3 and 4).
= −D rh h2
4
2
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where D is the corrected oligomer diameter and w = 2x is the
measured width at half-height. Similarly, tip widening of the
adsorbed oligomers was modeled as a spherical tip of radius R
in contact with another sphere of radius r located on a surface.
= − + + −y r R R r x( )2 2 (5)
where y is the height of the tip above the surface and w = 2x is
the measured width at height y. Because widths were measured
at half the measured oligomer height, we set y equal to r. Origin
software (OriginLab Corp., Northampton, MA) was used to
generate histograms and fitting curves in this section and all
others.
AFM Force Mapping. For force mapping experiments, the
atomic force microscope was changed to force volume mode
after imaging an area of interest. Forces of <12 nN and tip
velocities of 800 nm/s were used. Force curves were acquired
point by point in each point of a 32 × 32 array (force map).
Data processing for force mapping data was conducted by using
a custom-made MATLAB (Natick, MA) program. Break-
through forces were measured with this program by detecting
the force discontinuity during a breakthrough event. When no
event was detected, the breakthrough force was set to zero and
no further analysis was performed on that curve. Statistical
distributions of breakthrough forces were fit with Gaussian
functions. All experiments were performed at room temper-
ature. Actual spring constants were measured using the thermal
tune method before the experiments.48
Planar Lipid Bilayer Electrical Recording. For electrical
recording experiments with planar lipid bilayers (known as
BLM for black lipid membranes because they appear “black”
when viewed by reflected light),49,50 AβpE3−42 peptides were
dissolved in Milli-Q water to a concentration of 1 mg/mL and
subsequently used a single time. Membranes were composed of
DOPS/POPE mixtures (1:1 by weight) in heptane at a total
lipid concentration of 20 mg/mL. For membrane formation,
lipid was added directly over a hole (∼250 μm diameter) in a
Delrin septum (Warner Instruments, Delrin perfusion cup,
volume of 1 mL). As an electrolyte, we used 150 mM KCl, 10
mM HEPES (pH 7.4), and 1 mM MgCl2. Before data were
acquired, we verified that the bilayer was stable for several
minutes with a low conductance (<10 pS) across an applied
voltage of ±100 mV and that the system capacitance was >110
pF. When both criteria were met, the peptide solution was
added to one of the compartments of the bilayer chamber (cis
side), reaching a final concentration of ∼10 μM. The solution
was stirred for 5 min before data were acquired. Bilayer stability
was monitored by periodic capacitance measurements. All
traces were recorded in voltage clamp mode using the 2 kHz
built-in filter cutoff of our BC-535 amplifier (Warner
Instruments, Hamden, CT). A sampling frequency of 15 kHz
was used for the acquisition of data. We used a custom-made
LabVIEW (National Instruments, Austin, TX) program to
record the current and Clampfit version 10.2 (Molecular
Devices) to analyze traces. For the representation in figures,
time traces were filtered with a digital Gaussian low-pass filter
with a cutoff frequency of 50 Hz.
■ RESULTS
Kinetics of AβpE3−42 Self-Assembly in Solution. The
ThT fluorescence was used to compare the kinetics of fibril self-
assembly for Aβ1−42 and AβpE3−42 peptides (Figure 1). AβpE3−42
peptides have faster self-assembly kinetics, indicated by a
considerably shorter lag phase and a faster elongation phase
Figure 1. Self-assembly kinetics of Aβ1−42 and AβpE3−42 measured by
thioflavin-T (ThT) fluorescence at 25 °C. The ThT intensity (I) was
monitored as a function of time (t) for (A) AβpE3−42 (black) and
Aβ1−42 (blue) solutions (fitted curve shown with a solid blue line) with
20 μM concentrations (a.u., arbitrary units) and (B) 5 μM (dark gray)
and 2.5 μM (light gray) solutions of AβpE3−42. Fitted curves are shown
with black lines. tlag and k were obtained from the fitted curves using
eqs 1 and 2.
Figure 2. AFM images of (A) AβpE3−42 and (B) Aβ1−42 aggregated
peptides after different periods of incubation. Images were acquired in
air. A 10 μL droplet was deposited on a mica surface for 5 min, rinsed
with ∼ 50 μL pure water and dried with gentle N2 flow. The vertical
color-coded scale is 10 nm everywhere except for the 48 h images,
where it is 50 nm.
Biochemistry Article
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(Figure 1A). The lag phase for AβpE3−42 becomes visible only at
the lower concentrations (Figure 1B). Their lag phase times
and rate constants using eqs 1 and 2 are as follows: tlag = 1.14 h
and k = 0.51 h−1 for the 5 μM solution, and tlag = 2.01 h and k =
0.31 h−1 for the 2.5 μM solution. From the fitted curves in
Figure 1A, we obtained a tlag of 13.51 h and a k of 0.46 h
−1 for
Aβ1−42. Our results are in good agreement with previous results
for Aβ1−40 and AβpE3−40,
51 although those lag phase times are
considerably longer. This is possibly due to the two additional
hydrophobic residues (Ile41 and Ala42) at the C-terminus of
the Aβ1−42 and AβpE3−42 peptides.
AFM was used to characterize the morphology of the self-
assembled species. Only globular and small linear oligomers
were seen in the initial state of the freshly prepared AβpE3−42
and Aβ1−42 oligomers (Figure 2). While annular AβpE3−42
protofibrils were already seen after incubation for 30 min at
room temperature (Figure 2A), globular Aβ1−42 oligomers were
still found even after incubation for 14 h (Figure 2B). The
diameters of AβpE3−42 oligomers changed significantly after 0.5
h, whereas the diameters of Aβ1−42 oligomers remained
approximately constant after 14 h (Table 1). The heights
changed by a factor of ∼2 for both peptides (Table 1). As
regions with high concentrations of AβpE3−42 fibrils were already
seen after 48 h (Figure 2A), only protofibrils and large
quantities of Aβ1−42 oligomers were observed (Figure 2B).
Aβ1−42 fibrils were found only after incubation for several days.
These results correlate well with the ThT data discussed above
(Figure 1A).
Membrane-Adsorbed AβpE3−42 Oligomers. We used
AFM to characterize the morphology of Aβ oligomers adsorbed
on anionic membranes and the loss of membrane integrity
induced by these oligomers. We attempted to monitor the
adsorption of AβpE3−42 oligomers when they were allowed to
interact with preformed supported lipid bilayers. We did not
observe oligomer adsorption even after incubation for several
hours in the AFM liquid cell. Instead, fibrils were observed on
membrane regions after ex situ incubation for 38 h (Figure 3).
Significantly, membrane patches appeared to be intact without
a substantial number of adsorbed AβpE3−42 oligomers or
apparent defects in the lipid bilayer. These results suggest
Table 1. Heights (h), Widths (W), and Diameters (D) for the
Globular and Annular Oligomers of Aβ1−42 and AβpE3−42
Shown in Figure 2 at the Indicated Times (n = 28 for all
entries)a
Aβ1−42
(t = 0)b
AβpE3−42
(t = 0)b
Aβ1−42
(t = 14 h)b
AβpE3−42
(t = 0.5 h)b
h (nm) 1.7 ± 0.7 1.1 ± 0.6 3.9 ± 1.6 2.3 ± 0.9
W (nm) 18.3 ± 4.4 22.1 ± 6.4 19.0 ± 4.4 136.4 ± 33.8c
D (nm) 7.3 ± 3.1 10.1 ± 5.0 7.7 ± 3.1 136.4 ± 33.8c
aThe tip widening effect was considered for D using eq 5. bValues are
presented as averages ± the standard deviation. cThe peak−peak
distance (not affected by tip widening) was measured.
Figure 3. AFM (A) height and (B) amplitude images of AβpE3−42
fibrils formed on a supported DOPS/POPE (1:1) lipid membrane
after incubation for 38 h at room temperature. Fibril structures on a
seemingly intact membrane are observed. The vertical color-coded
scale is 25 nm for panel A.
Figure 4. AFM images of (A) AβpE3−42 oligomers and membrane defects induced by the oligomers in a DOPS/POPE (1:1) lipid bilayer and (B)
Aβ1−42 oligomers adsorbed on a lipid bilayer with the same composition described above. (C) Aβ1−42 oligomers adsorbed on a lipid bilayer with a
lower peptide:lipid ratio. The peptide:lipid mass ratios are 1:2 in panels A and B and 1:10 in panel C.
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weak interactions between AβpE3−42 oligomers and headgroups
in the lipid membrane. In comparison, oligomeric and fibrillar
self-assembled structures of full-length Aβs were found to form
on different supported membranes.52−56
To increase the probability of Aβ peptides interacting with
membrane lipids, lipids were hydrated into liposomes in the
presence of peptides, subsequently sonicated together, and
finally extruded to form unilamellar proteoliposomes. Following
this method, large quantities of AβpE3−42 oligomers adsorbed on
a seemingly flat membrane were seen (Figure 4A). The
adsorbed AβpE3−42 oligomers (green circles) have typical
diameters in the range of 30−40 nm and heights of 2−10
nm (Figures 4A and 5A,C and Table 2). In addition, bilayer
deep (∼5 nm) gaps separating regions of seemingly intact
patches are observed. Smaller structures (≤2 nm in height) are
found in these flatter regions, suggesting the presence of
membrane-inserted oligomers. We compared the density and
dimensions of adsorbed AβpE3−42 oligomers with those of
Aβ1−42 oligomers. The Aβ1−42 oligomers have higher concen-
trations (∼200 oligomers/μm) and smaller dimensions
compared to those of the AβpE3−42 oligomers even though
their heights are similar (Figures 4B and 5A,C and Table 2). In
addition, a large surface density of membrane defects with
depths of one bilayer (dark spots) is observed. At lower
peptide:lipid ratios (Figure 4C), the number of these defects
was no longer significant and most of the observed structures
protruded ≤2 nm from the bilayer plane, suggesting a majority
of inserted oligomers.
Membrane-Inserted AβpE3−42 Oligomers. In addition to
the adsorbed oligomers discussed above, we observed
numerous smaller structures protruding <2 nm from the
membrane plane (red circles in Figures 4A,B). These structures
are attributed to populations of oligomers inserted into the
membrane. Similar to the membrane-adsorbed oligomers, the
inserted Aβ1−42 oligomers have higher concentrations and
smaller dimensions compared to those of the AβpE3−42
oligomers (Figures 4A,B and 5B,D and Table 2). Most of
these oligomers have a globular appearance (Figure 6A),
although a smaller subpopulation of pore-forming oligomers
was also found (inset). Their electrophysiological activity is
indicated by discrete features in the ionic current passing
through the lipid membrane (Figure 6B), with pore
conductances of <0.7 nS.57 From these data, the pore diameters
can be roughly approximated (Figure 6C) using eq 6:58,59
π
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with r is the pore radius, r0 = G/4σ, G is the single-pore
conductance, σ is the solution conductivity (∼1.5 S/m for 150
mM KCl), and L is the pore length (∼6 nm). After longer
recording times (∼20 min following the first activity) and in
approximately 50% of our experiments, an exponential-like
phase was observed before the saturation current of the
amplifier was reached.57
We conducted force measurements on membrane patches
with inserted AβpE3−42 oligomers. We characterized the
mechanical properties of these membranes by measuring the
breakthrough force seen in indentation curves. These curves
show that lipid membranes are first deformed elastically by the
AFM tip (O−FB region in Figure 7A). At the critical
breakthrough force, marked by a discontinuity in the curve,
the membrane undergoes an irreversible (plastic) deformation.
The breakthrough force has been characterized for different
lipid membranes and found to be sensitive to lipid composition,
ionic strength, and temperature.60−69 We measured a value of
1.31 ± 0.22 nN (mean value ± the half-width at half-
Figure 5. Diameter and height histograms of inserted and adsorbed
oligomers obtained from AFM images similar to Figure 4. (A)
Diameter (D) histograms for membrane-adsorbed oligomers of
AβpE3−42 (blue) and Aβ1−42 (black). AβpE3−42 oligomers have a
diameter DA(AβpE3−42) of 43.8 ± 7.6 nm, while DA(Aβ1−42) = 21.5 ±
7.6 nm for Aβ1−42 oligomers. (B) Diameter histograms for inserted
oligomers. Inserted AβpE3−42 oligomers (blue) have a diameter
DI(AβpE3−42) of 26.0 ± 7.1 nm, whereas DI(Aβ1−42) = 13.8 ± 4.8
nm for Aβ1−42 oligomers (black). Diameters were measured as
described in the Methods section. (C) Height (h) histograms for
membrane-adsorbed oligomers of AβpE3−42 (blue) and Aβ1−42 (black).
AβpE3−42 oligomers have a height hA(AβpE3−42) of 5.7 ± 1.5 nm, while
hA(Aβ1−42) = 6.2 ± 2.4 nm for Aβ1−42 oligomers. (D) Height
histograms for inserted oligomers of AβpE3−42 (blue) and Aβ1−42
(black). AβpE3−42 oligomers have a height hI(AβpE3−42) of 1.4 ± 0.2
nm, while hI(Aβ1−42) = 1.8 ± 0.4 nm for Aβ1−42 oligomers. Histograms
were fit using a Gaussian function, and D and h values are given as
peak center values ± the half-width at half-maximum of the
distribution. A height of 2 nm was chosen as the boundary between
inserted and adsorbed species. n = 20 for all histograms, except n = 30
for DI(Aβ1−42) and hI(Aβ1−42).
Table 2. Densities (nO) of Membrane-Associated Oligomers (inserted and adsorbed) and Measured Widths, Diameters, and
Heights of Inserted and Adsorbed Aβ1−42 and AβpE3−42 Oligomers (WI, DI, hI, WA, DA, and hA, respectively)
a
peptide nO (μm
−2) WI (nm)
b WA (nm)
b DI (nm)
c DA (nm)
c hI (nm)
b hA (nm)
b
AβpE3−42 43 38.2 ± 6.9 62.2 ± 12.5 26.0 ± 7.08 43.8 ± 7.6 1.4 ± 0.2 5.7 ± 1.5
Aβ1−42 195 22.7 ± 6.7 33.5 ± 5.7 13.8 ± 4.77 21.5 ± 7.6 1.8 ± 0.4 6.2 ± 2.4
anO was measured using particle analysis for all oligomers in panels A and B of Figure 4, while all other values were measured for individual
oligomers; n = 20 everywhere, except n = 30 for DI(Aβ1−42) and hI(Aβ1−42).
bValues are represented as peak centers ± the half-width at half-
maximum from the Gaussian fitting. cDiameters were obtained from the measured widths by taking into account eqs 3−5 for tip deconvolution.
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maximum) for the breakthrough force of DOPS/POPE
membranes. Insertion of AβpE3−42 oligomers significantly
increased this value by ∼40% (Figure 7B−D).
■ DISCUSSION
Using ThT fluorescence, we have found that self-assembly of
AβpE3−42 oligomers into fibrils has faster kinetics than that of
Aβ1−42 (Figure 1). During the first phase, the lag phase,
monomers and small oligomers nucleate with very slow kinetics
into β-structured oligomers serving as nucleation seeds. In the
second phase, these seeds elongate into amyloid fibrils at a
much faster rate as more peptides are incorporated into the
preformed seeds. Hydrophobic interactions and hydrogen
bonding are the driving forces behind the self-assembly
processes leading to amyloid fibril formation.70 A recent 19F
NMR study has reported multiple oligomeric species in the lag
phase, including α-helix and reversible β-sheet oligomers.71 In
addition, it has been reported that Aβ1−40 adopts a compact,
partially folded structure, forming a 310-helix in the H13−D23
central hydrophobic region,72 and that these helical inter-
mediates are crucial intermediates in amyloid self-assembly.
Annular protofibrils with polygonal appearances and
diameters of 8−25 nm have been observed by transmission
electron microscopy (TEM) for Aβ1−42 as a product of their
aggregation process.73 The diameters of the AβpE3−42 annular
protofibrils we found (Figure 2A) are significantly larger,
ranging from 80 to 200 nm (Table 1). The shapes we observed
agree with the TEM observations for Aβ1−42; thus, they cannot
be attributed to AFM imaging artifacts. Although annular
protofibrils have been reported for many different amy-
loids,12,16,74,75 their structures, interrelationships, and contribu-
tions to disease pathogenesis are not entirely clear.73
We have considered mechanisms of membrane permeability
and loss of membrane structural integrity induced by AβpE3−42
oligomers (i) adsorbed on the membrane and (ii) inserted into
the membrane. We observed a higher surface density of
adsorbed AβpE3−42 oligomers when they were allowed to
interact with lipids during lipid hydration and lipid self-
assembly into liposomes (method 1) than when the oligomers
were injected on preformed supported bilayers (method 2).
This observation suggests that the former oligomers have a
different, more favorable membrane-binding conformation than
the latter. The additional energy necessary for oligomers to
acquire this conformation might be provided during the
sonication step in method 1. The higher fluidity of the
liposome membrane might also facilitate rearrangement of the
peptide in method 1, compared to the surface-supported
membrane of method 2.
We found significantly larger dimensions and lower densities
for membrane-adsorbed and membrane-inserted AβpE3−42
oligomers than for Aβ1−42 oligomers (Figures 4 and 5 and
Table 2). The larger size of AβpE3−42 oligomers is attributed to
their faster kinetics of self-assembly (Figures 1 and 2). The
higher density of Aβ1−42 oligomers appears to be counter-
intuitive because of the repulsion expected between the
negatively charged Asp1 and Glu3 residues of Aβ1−42, with
the also negatively charged PS headgroups in the membrane.
However, this higher density of Aβ1−42 oligomers is under-
standable if we hypothesize that PE-reach domains are induced
by Aβ1−42 oligomers due to attractive charge−dipole
interactions between the negatively charged residues and the
zwitterionic PE headgroups (Figure 8), thus leading to
formation of PE-rich proteoliposomes during lipid hydration
Figure 6. (A) AFM image of AβpE3−42 oligomers inserted into a DOPS/POPE (1:1) membrane. A subpopulation of these oligomers forms pore
structures. (B) Electrical recording data demonstrating the activity induced by AβpE3−42 pore-forming oligomers. (C) Pore diameters estimated from
eq 6 for the interval of single-pore conductances measured in our experiments (0−0.7 nS).
Figure 7. AFM force measurements demonstrating the effect of
membrane-inserted AβpE3−42 oligomers on the mechanical properties
of DOPS/POPE membranes. (A) Indentation curves (only approach
is shown) for DOPS/POPE membranes without (blue) and with (red)
inserted AβpE3−42 oligomers displaying the breakthrough forces (FB)
and thicknesses (h) of the membranes. F is the force, and δ is the tip−
sample separation. (B) Histograms of breakthrough forces show FB1 =
1.31 ± 0.19 nN for the DOPS/POPE membrane and FB2 = 1.83 ±
0.25 nN for a similar membrane with inserted AβpE3−42 oligomers. (C
and D). Force maps of the analyzed data for (C) the DOPS/POPE
membrane and (D) the DOPS/POPE membrane with inserted
AβpE3−42 oligomers. The outline of the membrane patch is seen in
panel D. An FB value of 0 was given to curves that did not show
breakthrough forces outside the membrane. These curves were not
analyzed further. The peptide:lipid ratio is 1:10 for all data.
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in our proteoliposome preparation protocol (method 1). In
addition, the larger size of AβpE3−42 oligomers would increase
the barrier for membrane insertion leading to lower densities of
inserted AβpE3−42 oligomers. However, once the peptide is
inserted, the stronger interactions of the more hydrophobic
AβpE3−42 with the lipid tails would lead to a more stable
conformation in the hydrophobic lipid core.
We interpret the high level of fragmentation of supported
membranes formed from Aβ1−42 proteoliposomes (Figure 4B)
to be due to insufficient vesicle fusion induced by the high
concentration and steric repulsion of membrane-inserted
Aβ1−42 oligomers (Figure 8). The larger dimensions of inserted
and adsorbed AβpE3−42 oligomers (Figure 5 and Table 2) are
attributed to their faster kinetics of self-assembly (Figures 1 and
2 and Table 1). We believe that even relatively low
concentrations of AβpE3−42 oligomers can produce high
cytotoxicity because of higher level of pore formation and
higher stability in the membrane. Our BLM results indicating a
larger populations of high-conductance AβpE3−42 pores as well
as our molecular dynamics (MD) simulations indicating a more
stable membrane conformation of inserted AβpE3−42 pore
structures lead to a similar conclusion.57
Among the populations of membrane-inserted oligomers,
pore structures are observed less frequently than globular
structures, suggesting that the former structures represent a
minority population in the membrane. This is partly due to
experimental difficulties in achieving a sufficiently high
resolution by AFM, including the inability of broad tips to
resolve pore features and the potential distortion of pore
structures induced by tip−sample interactions. It should be
noted, however, that even small pore populations have the
ability to produce high cytotoxicity. It was estimated that a
single pore with a 4 nS conductance would produce a loss of
cell homeostasis in seconds.76,77 A group of pores with the
conductances observed in our data (≤0.7 nS) would lead to a
similar result.
Because of the different sensitivities between AFM imaging
and BLM, higher pore concentrations are required for AFM
imaging. For BLM, the opening of a single pore can produce a
detectable increase in the current across the bilayer. As bilayer
areas have typical dimensions of ∼104 μm2, pore densities of
∼10−4 pores/μm2 can be detected by BLM. However, pore
densities of ∼102−103 pores/μm2 are necessary for optimal
AFM imaging (1−10 pores for 100 nm × 100 nm imaging
areas). Therefore, BLM provides information about early stages
of pore formation when pore densities are low, while AFM
gives information about later stages when the concentration of
membrane-inserted oligomers is higher.
The pore diameters found using eq 6 (Figure 5C) are in
general smaller than those predicted in MD simulations and
seen by AFM imaging (Table 3). The relation in eq 6 assumes a
cylindrical geometry with no charge along the length of the
pore, while Aβ pores have a charged surface and a nonuniform
geometry. As a result, the relation provides only a very rough
estimate of pore diameter that is used as a “ballpark” figure.
With this in mind, the calculated diameters compare reasonably
well with the inner diameters of Aβ pores found using MD
simulations and AFM imaging (∼1.5−2.5 nm). The structures
of these membrane-embedded pores have been well charac-
terized by AFM for full-length Aβs,13,14,43 Aβ1−42 point
substitutions,78 Aβ fragments,27,44 and other amyloidogenic
proteins.14,79 Here, they were not investigated in detail. The
Figure 8. Schematics of supported membrane (SM) formation via proteoliposome (PL) rupture and fusion. (A) Aβ1−42 proteoliposomes having a
very high concentration of membrane-inserted oligomers are not able to form supported membranes by fusion of ruptured proteoliposomes. (B)
AβpE3−42 proteoliposomes have lower concentrations of inserted oligomers, thus being able to form supported membranes. The dimensions of the
inserted and adsorbed AβpE3−42 oligomers are larger because of faster aggregation kinetics. Attractive interactions between Aβ1−42 and PE headgroups
induce PE-rich proteoliposomes.
Table 3. Comparison of Pore Diameters for AβpE3−42, Aβ1−42,
and Aβ17−42 Obtained from eq 6, MD Simulations, and AFM
peptide pore diameter (nm) method
any 0.7−2.1 eq 6 for 100−700 pS
AβpE3−42 ∼2.2 (18-mer, conformer 1) MD57
∼1.9 (18-mer, conformer 2)
Aβ1−40 ∼1.0−2.0 AFM14
Aβ1−42 ∼1.9 (18-mer, conformer 1,
D-isomer)
MD43,78,90
∼2.1 (18-mer, conformer 2,
D-isomer)
∼1.8−2.2 (18-mer, conformer 1,
L-isomer)
∼1.9−2.2 (18-mer, conformer 2,
L-isomer)
Aβ17−42 ∼1.0−2.0 AFM44
∼1.7 (16-mer channel) MD44
∼0.8, ∼1.9, ∼2.5−2.7 (12-, 20-, and
24-mer channels)
MD91,92
∼1.8, ∼1.5, ∼2.2 (12-, 16-, and
20-mer barrels)
MD93
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pore diameters for 18-mers of AβpE3−42 found using atomistic
MD simulations were 1.9 and 2.2 nm for two different Aβ
conformers.57
We measured a 40% increase in the breakthrough force of
membranes allowed to interact with AβpE3−42 oligomers using
method 1 of sample preparation. For these experiments, we
used a 1:10 peptide:lipid ratio. At this ratio, we observed a
sizable population of inserted AβpE3−42 oligomers (Figure 6),
but not many adsorbed oligomers. In the presence of the latter
population, the mechanical response measured by the tip likely
would have been dominated by the adsorbed oligomers directly
under the tip, not by their influence on the mechanical
properties of the membrane. Therefore, our results indicate that
the population of inserted oligomers induces a significant
modification of the mechanical properties of the membrane.
The higher breakthrough force measured for membranes
with inserted AβpE3−42 oligomers would suggest (i) the
presence of local populations of rigid β-sheet oligomers,
leading to increased local stiffness, or (ii) an increased global
ordering of the membrane lipids induced by the AβpE3−42
oligomers, thus leading to a global increase in the stiffness of
the membrane, similar to the modulation of membrane stiffness
induced by cholesterol molecules.80−87 From our measure-
ments, we cannot discriminate which mechanism is predom-
inant. Both stiffer and more flexible membranes could lead to
higher membrane permeability, although by different mecha-
nisms. A membrane hole would likely heal slower for stiffer
membranes, thus enhancing permeability, and a more flexible
hole would decrease the membrane thickness, also leading to
increased permeability. Previous results found the breakthrough
force of POPC/POPS membranes to increase when they were
allowed to interact with Aβ1−40 oligomers and to be dependent
on the aggregation state of the peptide.88 Significantly, Aβ1−42
oligomers induced a decrease in the breakthrough force of
supported membranes.89 Some variability in the results is not
surprising, as the free energy landscape of Aβs has been found
to be highly dependent on the exact experimental con-
ditions.27,28,70
■ CONCLUSIONS
We have examined the effect of AβpE3−42 oligomers on the ion
permeability and the structural and mechanical properties of
anionic lipid membranes. We have found lower concentrations
and larger dimensions for the adsorbed and membrane-inserted
AβpE3−42 oligomers compared to those of Aβ1−42. The larger
sizes of AβpE3−42 oligomers are attributed to their faster kinetics
of self-assembly. The lower concentrations are attributed to
their weaker interactions with the membrane lipids. However,
once inserted into the membrane, these larger AβpE3−42
oligomers induce considerable ion permeability through the
membrane and are stable in the lipid core of the membrane
because of their increased hydrophobicity. The adsorbed
AβpE3−42 oligomers appeared to have little effect on the
structural integrity of the membrane. Membrane permeabiliza-
tion can be understood more easily as a result of the membrane
oligomers. These oligomers also produced a change in the
mechanical properties of the membrane, suggesting a
reordering of membrane structure.
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